HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,715,000 | +98180.3% | 9,108,000 | -3.3% | 0.80% | +11.7% |
| Q2 2023 | $7,850 | -2.0% | 9,418,000 | -0.3% | 0.72% | -1.8% |
| Q1 2023 | $8,011 | -15.2% | 9,443,000 | -2.5% | 0.73% | -16.6% |
| Q4 2022 | $9,444 | -99.9% | 9,688,000 | -2.9% | 0.87% | +14.0% |
| Q3 2022 | $8,481,000 | -4.1% | 9,978,000 | 0.0% | 0.77% | -8.7% |
| Q2 2022 | $8,843,000 | -41.0% | 9,978,000 | -41.3% | 0.84% | -36.4% |
| Q1 2022 | $14,985,000 | – | 16,992,000 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 70,776,482 | $60,420,911 | 4.46% |
| Lombard Odier Asset Management (Europe) Ltd | 41,798,000 | $35,110,320 | 1.74% |
| CAMDEN ASSET MANAGEMENT L P /CA | 47,123,000 | $39,937,073 | 1.34% |
| Penn Mutual Asset Management | 1,555,000 | $1,318,197 | 1.25% |
| DAVIDSON KEMPNER PARTNERS | 66,537,000 | $56,390,573 | 1.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 66,537,000 | $56,390,573 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,443,000 | $8,011 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,934,000 | $7,582,430 | 0.58% |
| CSS LLC/IL | 8,000,000 | $6,788,288 | 0.45% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,262,534 | 0.40% |